Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Daiichi Sankyo
Queensland Health
Mallinckrodt
Medtronic
Moodys
Baxter
QuintilesIMS
Julphar

Generated: August 18, 2018

DrugPatentWatch Database Preview

DESONIDE - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for desonide and what is the scope of desonide freedom to operate?

Desonide is the generic ingredient in four branded drugs marketed by Aqua Pharms, G And W Labs Inc, Glenmark Pharms, Perrigo New York, Taro, Galderma Labs Lp, Bayer Hlthcare, Fougera Pharms, Taro Pharm, Teligent Pharma Inc, Glenmark Pharms Ltd, and Hi-tech Pharmacal, and is included in eighteen NDAs. There are six patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Desonide has eighty-one patent family members in twenty-five countries.

There are thirty drug master file entries for desonide. Seventeen suppliers are listed for this compound.

Pharmacology for DESONIDE
Medical Subject Heading (MeSH) Categories for DESONIDE
Synonyms for DESONIDE
(11ss,16alpha)-11,21-Dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-pregna-1,4-diene-3,20-dione
(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.0;{2,9}.0;{4,8}.0;{13,18}]icosa-14,17-dien-16-one
(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with acetone
11beta,21-dihydroxy-16alpha,17-[(1-methylethylidene)bis(oxy)]pregna-1,4-diene-3,20-dione
11beta,21-dihydroxy-16alpha,17-isopropylidenedioxypregna-1,4-diene-3,20-dione
11beta,21-dihydroxy-16alpha,17alpha-isopropylidenedioxypregna-1,4-diene-3,20-dione
16-alpha-Hydroxyprednisole-16,17-acetonide
16?,17-[1-Methylethylidenebis(oxy)]-11?,21-dihydroxypregna-1,4-diene-3,20-dione
16alpha-hydroxyprednisole-16,17-acetonide
16alpha-hydroxyprednisolone-16alpha,17-acetonide
16alpha,17-[1-Methylethylidenebis(oxy)]-11beta,21-dihydroxypregna-1,4-diene-3,20-dione (Desonide)
16alpha,17alpha-isopropylidenedioxyprednisolone
638-94-8
638D948
AB01274712_02
AB01274712-01
AB2000229
Apolar
AS-13892
budesonide acetonide
C-22009
CAS-638-94-8
CC-26356
CCG-221279
CHEBI:204734
CHEMBL1201109
CS-2228
D 2083
D-2083
D02JNM
D03696
D2083
DB01260
desfluorotriamcinolone acetonide
Desilux
Desonate
Desonida
Desonida [INN-Spanish]
Desonide (USAN/INN)
Desonide [USAN:INN:BAN]
Desonidum
Desonidum [INN-Latin]
DesOwen
Desowen (TN)
DSSTox_CID_26756
DSSTox_GSID_46756
DSSTox_RID_81880
DTXSID7046756
EINECS 211-351-6
Flusemidon
GTPL7066
Hamiltoderm
HY-B0248
J280872D1O
K016
Locapred
Locapred, Topifug, Tridesilon, Desonide
Locapred;Topifug;Tridesilon
MolPort-003-987-087
NCGC00167983-01
NCGC00274065-01
Prednacinolone
Prednisolone-16,17-acetonide, 16-alpha-hydroxy-
Pregna-1,4-diene-3,20-dione, 11,21-dihydroxy-16,17-((1-methylethylidene)bis(oxy))-, (11beta,16alpha)-
Prenacid
Q-101382
Reticus
s1701
SC-17104
SCHEMBL3631
Sterax
Steroderm
TL8004516
Topifug
Tox21_112603
Tox21_112603_1
Tridesilon
Tridesonit
UNII-J280872D1O
Verdeso
Verdeso (TN)
Verdeso Foam (TN)
WBGKWQHBNHJJPZ-LECWWXJVSA-N
ZINC4212851
Zotinar

US Patents and Regulatory Information for DESONIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aqua Pharms VERDESO desonide AEROSOL, FOAM;TOPICAL 021978-001 Sep 19, 2006 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Bayer Hlthcare DESONATE desonide GEL;TOPICAL 021844-001 Oct 20, 2006 RX Yes Yes ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Aqua Pharms VERDESO desonide AEROSOL, FOAM;TOPICAL 021978-001 Sep 19, 2006 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Aqua Pharms VERDESO desonide AEROSOL, FOAM;TOPICAL 021978-001 Sep 19, 2006 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Non-Orange Book US Patents for DESONIDE

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,449,867 Microemulsion and sub-micron emulsion process and compositions ➤ Sign Up
8,263,580 Vitamin formulation ➤ Sign Up
8,298,515 Vitamin formulation ➤ Sign Up
8,629,128 Vitamin formulation ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Supplementary Protection Certificates for DESONIDE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
00617 Netherlands ➤ Sign Up PRODUCT NAME: COMBINATIE VAN CLINDAMYCINE, DESGEWENST IN DE VORM VAN CLINDAMYCINEFOSFAAT EN TRETINOINE; NAT. REGISTRATION NO/DATE: RVG 109745 20130626; FIRST REGISTRATION: PA1332/043/001 20130322
90049-3 Sweden ➤ Sign Up PRODUCT NAME: KLINDAMYCIN (SOM KLINDAMYCINFOSFAT) OCH TRETINOIN; NAT. REG. NO/DATE: MTNR 46193 20130503; FIRST REG.: IR PA1332/043/001 20130322
401 Luxembourg ➤ Sign Up PRODUCT NAME: CLINDAMYCINE(EN TANT QUE PHOPSHATE DE CLINDAMYCINE)ET TRETINOINE
1304992/01 Switzerland ➤ Sign Up PRODUCT NAME: CLINDAMYCINI PHOSPHAS ET TRETINOINUM; REGISTRATION NO/DATE: SWISSMEDIC 62513 28.03.2014
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Chubb
Cipla
Federal Trade Commission
Harvard Business School
US Department of Justice
Daiichi Sankyo
QuintilesIMS
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.